PW MEDTECH(01358)

Search documents
普华和顺9月5日斥资110.32万港元回购78.8万股
Zhi Tong Cai Jing· 2025-09-05 10:58
Group 1 - The company PwC announced a share buyback plan on September 5, 2025, involving an expenditure of HKD 1.1032 million [1] - A total of 788,000 shares will be repurchased at a price of HKD 1.4 per share [1]
普华和顺(01358)9月5日斥资110.32万港元回购78.8万股
智通财经网· 2025-09-05 10:55
Core Viewpoint - PwC announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company will repurchase 788,000 shares at a total cost of HKD 1.1032 million [1] - The buyback price per share is set at HKD 1.4 [1] - The buyback is scheduled to take place on September 5, 2025 [1]
普华和顺(01358) - 翌日披露报表
2025-09-05 10:51
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 普华和顺集团公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2025年9月5日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01358 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | | 庫存股份變動 | | | | | ...
普华和顺(01358)9月4日斥资93.8万港元回购67.4万股
Zhi Tong Cai Jing· 2025-09-04 12:09
Group 1 - The company PwC and Shun (01358) announced a share buyback on September 4, 2025, spending HKD 938,000 to repurchase 674,000 shares [1]
普华和顺9月4日斥资93.8万港元回购67.4万股
Zhi Tong Cai Jing· 2025-09-04 12:07
Group 1 - The company, PwC and Shun (01358), announced a share buyback plan on September 4, 2025, involving an expenditure of HKD 938,000 to repurchase 674,000 shares [1]
普华和顺(01358.HK)9月4日耗资93.81万港元回购67.4万股
Ge Long Hui· 2025-09-04 12:03
Core Viewpoint - PwC Holdings (01358.HK) announced a share buyback of 674,000 shares at a cost of HKD 938,100 on September 4 [1] Group 1 - The company executed a buyback program, indicating a strategy to enhance shareholder value [1] - The total expenditure for the buyback was HKD 938,100, reflecting the company's commitment to returning capital to shareholders [1] - The number of shares repurchased was 674,000, which may influence the stock's liquidity and market perception [1]
普华和顺(01358) - 翌日披露报表
2025-09-04 11:56
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 普华和顺集团公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2025年9月4日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | | 是 | | | 證券代號 (如上市) | 01358 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | | 庫存股份變動 | | | | | | ...
普华和顺(01358) - 截至2025年8月31日之股份发行人的证券变动月报表
2025-09-04 08:06
呈交日期: 2025年9月4日 FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: 普華和順集團公司 ( 於開曼群島註冊成立的有限公司) FF301 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01358 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | 5,000,000,000 | USD | | 0.0001 | USD | | 500,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | 0 | | 本月底結存 | | 5,000,000,000 | USD | | 0.0001 | USD | | 500,000 ...
普华和顺(01358.HK)9月3日耗资92.3万港元回购66万股
Ge Long Hui· 2025-09-03 10:45
Core Viewpoint - PwC Holdings (01358.HK) announced a share buyback on September 3, spending HKD 923,000 to repurchase 660,000 shares [1] Related Events - On September 2, PwC Holdings spent HKD 644,000 to buy back 460,000 shares [1]
普华和顺(01358)9月3日斥资92.33万港元回购66万股
智通财经网· 2025-09-03 10:39
Core Viewpoint - PwC announced a share buyback plan, indicating confidence in its financial position and future growth potential [1] Summary by Relevant Categories Company Actions - The company plans to repurchase 660,000 shares at a cost of HKD 923,300 [1] Financial Implications - The share buyback reflects the company's strategy to enhance shareholder value and may positively impact the stock price [1]